Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008;30(4):254-65.
doi: 10.1159/000135644. Epub 2008 Jun 2.

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study

P J Visser  1 , F R J Verhey, M Boada, R Bullock, P P De Deyn, G B Frisoni, L Frolich, H Hampel, J Jolles, R Jones, L Minthon, F Nobili, M Olde Rikkert, P-J Ousset, A-S Rigaud, P Scheltens, H Soininen, L Spiru, J Touchon, M Tsolaki, B Vellas, L-O Wahlund, G Wilcock, B Winblad
Affiliations
Comparative Study

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study

P J Visser et al. Neuroepidemiology. 2008.

Abstract

Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predementia phase, but validated diagnostic approaches are currently lacking. In this paper, we present the background, design and methods of a study, which aims to develop clinical criteria for predementia AD. We also present baseline characteristics of the subjects included. The study was part of the multicentre DESCRIPA project, which is being conducted within the network of the European Alzheimer's Disease Consortium.

Methods: Clinical criteria will be based on a prospective cohort study of non-demented subjects older than 55 years and referred to a memory clinic. At baseline, a number of markers and risk factors for AD were collected, including demographic variables, measures of performance in activities of daily living, cognitive, neuroimaging and genetic markers, and serum and cerebrospinal fluid markers. Subjects will be reassessed annually for 2-3 years, and we will evaluate which combination of variables best predicts AD-type dementia at follow-up.

Results: Between 2003 and 2005, 881 subjects were included from 20 memory clinics. Subjects were on average 70.3 years old, and had 10.4 years of education. The average score on the Mini-Mental State Examination was 27.4.

PubMed Disclaimer

References

    1. Ott A, Breteler M, van Harskamp F, Claus J, van der Cammen T, Grobbee D, Hofman A. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ. 1995;310:970–973. - PMC - PubMed
    1. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work-Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939–944. - PubMed
    1. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–746. - PubMed
    1. Visser P. Mild cognitive impairment. In: Pathy MSJ, Morley JE, Sinclair A, editors. Principles and Practice of Geriatric Medicine. London: John Wiley & Sons; 2006. pp. 1095–1103.
    1. Visser PJ, Verhey FRJ, Scheltens P, Cruts M, Ponds RWHM, Hofman PAM, Van Broeckhoven CM, Jolles J. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol. 2002;249:312–319. - PubMed

Publication types